Large-scale testing (Phase 3)Study completedNCT02128061
What this trial is testing
Efficacy of Lenalidomide in Combination With Subcutaneous Rituximab + miniCHOP in DLBCL Patients of 80 y/o or+
Who this might be right for
Diffuse Large B Cell Lymphoma
The Lymphoma Academic Research Organisation 250